兔抗CLN6多克隆抗體

Background:

This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function.

Applications:

WB, IHC

Name of antibody:

CLN6

Immunogen:

Synthesized peptide derived from internal of human CLN6.

Full name:

ceroid-lipofuscinosis, neuronal 6, late infantile, variant

Synonyms：

nclf; CLN4A; HsT18960

SwissProt:

Q9NWW5

IHC positive control:

Human cervix tissue

IHC Recommend dilution:

50-100

WB Predicted band size:

36 kDa

WB Positive control:

Hela cells lysate

WB Recommended dilution:

500-3000